Patents by Inventor John H. Stone

John H. Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Minimally invasive implantable neurostimulation system
    Patent number: 11957893
    Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 16, 2024
    Assignee: Medtronic, Inc.
    Inventors: Brad C. Tischendorf, John E. Kast, Thomas P. Miltich, Gordon O. Munns, Randy S. Roles, Craig L. Schmidt, Joseph J. Viavattine, Christian S. Nielsen, Prabhakar A. Tamirisa, Anthony M. Chasensky, Markus W. Reiterer, Chris J. Paidosh, Reginald D. Robinson, Bernard Q. Li, Erik R. Scott, Phillip C. Falkner, Xuan K. Wei, Eric H. Bonde, David A. Dinsmoor, Duane L. Bourget, Forrest C M Pape, Gabriela C. Molnar, Joel A. Anderson, Michael J. Ebert, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Timothy J. Denison, Todd V. Smith
  • Minimally invasive implantable neurostimulation system
    Patent number: 11957894
    Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 16, 2024
    Assignee: Medtronic, Inc.
    Inventors: Anthony M. Chasensky, Bernard Q. Li, Brad C. Tischendorf, Chris J. Paidosh, Christian S. Nielsen, Craig L. Schmidt, David A. Dinsmoor, Duane L. Bourget, Eric H. Bonde, Erik R. Scott, Forrest C M Pape, Gabriela C. Molnar, Gordon O. Munns, Joel A. Anderson, John E. Kast, Joseph J. Viavattine, Markus W. Reiterer, Michael J. Ebert, Phillip C. Falkner, Prabhakar A. Tamirisa, Randy S. Roles, Reginald D. Robinson, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Thomas P. Miltich, Timothy J. Denison, Todd V. Smith, Xuan K. Wei
  • METHODS AND APPARATUS TO GENERATE CALIBRATION MODELS IN A CLOUD ENVIRONMENT
    Publication number: 20230194423
    Abstract: Methods and apparatus to generate calibration models in a cloud environment are disclosed. An example apparatus includes training circuitry to generate a calibration model based on a correlation of reference data and spectra, the reference data based on physical samples collected by one or more vehicles, the spectra associated with the physical samples, and distribution circuitry to provide, via a network communication, the calibration model to the one or more vehicles.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 22, 2023
    Inventors: Terence D. Pickett, Peter Schade, Broughton Boydell, John H. Stone
  • METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES
    Publication number: 20220389098
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Application
    Filed: May 16, 2022
    Publication date: December 8, 2022
    Applicant: Xencor, Inc.
    Inventors: Debra Zack, John H. Stone, Shiv Pillai, Paul Foster
  • Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases
    Patent number: 11365256
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 21, 2022
    Assignee: XENCOR, INC.
    Inventors: Debra Zack, John H. Stone, Shiv Pillai, Paul Foster
  • METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES
    Publication number: 20170355766
    Abstract: The present disclosure relates to immunoglobulins that bind Fc?RIIb+ B cells and coengage CD19 on the cell's surface and an Fc?RIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins for the treatment of an IgG4-related disease.
    Type: Application
    Filed: June 8, 2017
    Publication date: December 14, 2017
    Applicant: Xencor, Inc.
    Inventors: Debra Zack, John H. Stone, Shiv Patel, Paul Foster
  • METHODS FOR DIAGNOSING AND TREATING IMMUNE DISEASE
    Publication number: 20160159918
    Abstract: Provided are methods and assays relating to the treatment of an immune disease or disorder by administering an inhibitor that binds SLAMF7. Also provided are methods and assays related to the diagnosis of an immune disease or disorder by measuring expression level of SLAMF7 in a biological sample obtained from a subject.
    Type: Application
    Filed: July 24, 2014
    Publication date: June 9, 2016
    Inventors: Shiv PILLAI, John H. STONE, Hamid MATTOO, Vinay S. MAHAJAN
  • Rapid method for cleaning/disinfecting ophthalmic devices using novel glycol/lower alkanol solution
    Patent number: 5411598
    Abstract: A rapid cleaning and disinfecting method and composition for ophthalmic devices, e.g. contact lenses. The composition includes, on a weight basis, 10-50% of a C.sub.3-8 alkylene glycol, 2-30% of a lower alkanol, 2-15% of a surfactant, 0-2% pH adjusting agent, 0-5% tonicity builder, viscosity enhancing agent in an amount from 0 to the amount required to bring the solution viscosity to 100 cps, and the balance water. The method involves mechanically rubbing the ophthalmic device with the cleaning/disinfecting composition followed by rinsing the device.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: May 2, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Fu-Pao Tsao, Susan A. Littlefield, John H. Stone
  • Rapid ophthalmic disinfection method and solution using salt and glycol and/or lower alkanol
    Patent number: 5411597
    Abstract: A disinfection solution, primarily for use in conjunction with contact lenses is disclosed comprising an amount of a pharmaceutically acceptable ionic salt which is equivalent in ionic strength to at least 5% w/v sodium chloride, at least one of a C.sub.2-6 alkanol and a C.sub.3-8 alkylene glycol, a pharmaceutically acceptable surfactant, optionally a buffer, and water.
    Type: Grant
    Filed: September 3, 1993
    Date of Patent: May 2, 1995
    Assignee: Ciba-Geigy Corporation
    Inventors: Fu-Pao Tsao, Susan A. Littlefield, John H. Stone
  • Rapid ophthalmic glycol/lower alkanol cleaning and disinfecting solution and method
    Patent number: 5298182
    Abstract: A contact lens polymer material cleaning and disinfecting solution has about 21% by weight of a C.sub.3 -C.sub.8 alkylene glycol, about 16% by weight of a lower alkanol, and 5% by weight of an ophthalmic device material compatible surfactant, about 1% by weight of a pH adjusting or regulating agent, about 1% by weight of a tonicity builder, about 0.1% of a viscosity enhancing agent, and water.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: March 29, 1994
    Assignee: Ciba-Geigy Corporation
    Inventors: Fu-Pao Tsao, Susan A. Littlefield, John H. Stone